Evidence map›Paper›PMID 31545465›Full record

ArticleOncology reports2019

MicroRNA‑4712‑5p promotes proliferation of the vulvar squamous cell carcinoma cell line A431 by targeting PTEN through the AKT/cyclin D1 signaling pathways.

Shaojie Yang, Yanyan Zhao, Lufang Wang, Chang Liu, Ye Lu, Zhidong Fang, Hongshuang Shi, Wenyi Zhang, Xin Wu

Open access · hybridAbstract read
In one paragraph

Article in Oncology reports, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.3field-weighted citation impact, top 47% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Review
  6. Review
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Shaojie YangDepartment of Gynecology, The First Affiliated Hospital of China Medical University, Shenyang, Liaoning 110001, P.R. China.
Yanyan ZhaoDepartment of Gynecology, The First Affiliated Hospital of China Medical University, Shenyang, Liaoning 110001, P.R. China.
Lufang WangDepartment of Gynecology and Obstetrics, Union Hospital Affiliated to Tongji Medical College Huazhong University of Science and Technology, Wuhan, Hubei 430022, P.R. China.
Chang LiuDepartment of Gynecology, The First Affiliated Hospital of China Medical University, Shenyang, Liaoning 110001, P.R. China.
Ye LuDepartment of Gynecology, The First Affiliated Hospital of China Medical University, Shenyang, Liaoning 110001, P.R. China.
Zhidong FangChina Medical University, Shenyang, Liaoning 110122, P.R. China.
Hongshuang ShiDepartment of Gynecology, The First Affiliated Hospital of China Medical University, Shenyang, Liaoning 110001, P.R. China.
Wenyi ZhangRehabilitation Center, Shengjing Hospital of China Medical University, Shenyang, Liaoning 110134, P.R. China.
Xin WuDepartment of Gynecology, The First Affiliated Hospital of China Medical University, Shenyang, Liaoning 110001, P.R. China.
China Medical University · CNFirst Hospital of China Medical University · CNHuazhong University of Science and Technology · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The aim of the present study was to screen differentially expressed miRNAs in vulvar squamous cell carcinoma (VSCC), observe the role of microRNA‑4712‑5p in VSCC and investigate its targets and regulatory mechanism. Differentially expressed miRNAs in human VSCC tissues were screened. microRNA‑4712‑5p was selected and its expression level was verified in clinical tissue samples and the VSCC cell line A431 by reverse transcription‑quantitative polymerase chain reaction (RT‑qPCR) analysis. The overexpression vector of microRNA‑4712‑5p was prepared and transfected into A431 cells; subsequently, cell invasion and metastasis were examined by Cell Counting Kit‑8 and Transwell migration assays. Furthermore, the target gene of miRNA‑4712‑5p was predicted by bioinformatics and verified by The Dual‑Luciferase® Reporter (DLR™) Assay System. The expression of phosphatase and tensin homologue (PTEN) and its downstream proteins, such as protein kinase B (PKB; AKT), glycogen synthase kinase (GSK)3β and cyclin D1, were detected by western blot assays. The expression level of microRNA‑4712‑5p in VSCC tissues and the A431 cell line was found to be significantly increased, promoting proliferation and invasion of VSCC. The DLR™ assay indicated that PTEN was a target of miR‑4712‑5p. RT‑qPCR revealed that PTEN expression was markedly lower in VSCC tissues compared with that in adjacent tissues. After A431 cells were transfected with the miRNA‑4712‑5p overexpression vector, phospho‑AKT (p‑AKT) and cyclin D1 expression were notably increased, but miRNA‑4712‑5p‑targeted PTEN and phospho‑GSK3β (p‑GSK3β) protein markedly decreased. Therefore, microRNA‑4712‑5p can reduce the expression of PTEN, further affecting its downstream p‑AKT, p‑GSK3β and cyclin D1 signaling pathways, promoting the proliferation and invasion of VSCC.

Indexed as

3' Untranslated RegionsAged, 80 and overAnimalsCarcinoma, Squamous CellCell Line, TumorCell ProliferationCyclin D1FemaleGene Expression Regulation, NeoplasticGlycogen Synthase Kinase 3 betaHumansMiceMicroRNAsMiddle AgedNeoplasm TransplantationProto-Oncogene Proteins c-akt3' Untranslated RegionsCCND1 protein, humanCyclin D1Glycogen Synthase Kinase 3 betaGSK3B protein, humanMicroRNAsMIRN4712 microRNA, humanProto-Oncogene Proteins c-aktPTEN PhosphohydrolasePTEN protein, human

Identifiers

PMID31545465
PMCPMC6787978
OpenAlexW2974602226

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.